PMID- 32389047
OWN - NLM
STAT- MEDLINE
DCOM- 20210310
LR  - 20210310
IS  - 2047-9980 (Electronic)
IS  - 2047-9980 (Linking)
VI  - 9
IP  - 10
DP  - 2020 May 18
TI  - Survival Differences in Men and Women With Primary Malignant Cardiac Tumor: An 
      Analysis Using the Surveillance, Epidemiology and End Results (SEER) Database 
      From 1973 to 2015.
PG  - e014846
LID - 10.1161/JAHA.119.014846 [doi]
LID - e014846
AB  - Background No data are available on sex disparities in prevalence and survival 
      for primary malignant cardiac tumors (PMCT). This study aimed to compare male and 
      female PMCT prevalence and long-term survival rates. Methods and Results We 
      utilized the Surveillance, Epidemiology, and End Results (SEER) 18 database from 
      the National Cancer Institute for all PMCTs diagnosed between 1973 and 2015. From 
      a total of 7 384 580 cases of cancer registered in SEER, we identified 327 men 
      and 367 women with PMCTs. The majority (78%) of patients were white. Sarcoma was 
      the most common type of PMCT in both men and women ( approximately 60%). Individuals diagnosed 
      with lymphoma exhibited better survival than those with other types of PMCTs. Men 
      were diagnosed at a younger age than women; however, there was no significant 
      difference in overall survival between the sexes. Men diagnosed with PMCT between 
      the ages of 51 and 65 years demonstrated prolonged survival compared with those 
      diagnosed at younger or older ages. There was no difference in survival rates 
      among women based on age at diagnosis. Conclusions PMCTs are rare in both men and 
      women. Tumors tend to be diagnosed at an earlier age in men compared with women, 
      but there is no sex disparity in survival rate. Sarcoma is the most common type 
      of PMCT, and lymphoma is associated with the highest survival rate among both 
      sexes.
FAU - Antwi-Amoabeng, Daniel
AU  - Antwi-Amoabeng D
AD  - Department of Internal Medicine University of Nevada Reno School of Medicine Reno 
      NV.
FAU - Meghji, Zahara
AU  - Meghji Z
AD  - Department of Internal Medicine University of Nevada Reno School of Medicine Reno 
      NV.
FAU - Thakkar, Samarthkumar
AU  - Thakkar S
AD  - Department of Internal Medicine Rochester General Hospital Rochester NY.
FAU - Ulanja, Mark B
AU  - Ulanja MB
AD  - Department of Internal Medicine University of Nevada Reno School of Medicine Reno 
      NV.
FAU - Taha, Mohamed
AU  - Taha M
AD  - Department of Internal Medicine University of Nevada Reno School of Medicine Reno 
      NV.
AD  - Department of Internal Medicine University of Iowa Hospitals and Clinics Iowa 
      City IA.
FAU - Adalja, Devina
AU  - Adalja D
AD  - Department of General Medicine Gotri Medical Education and Research Center 
      Vadodara Gujarat India.
FAU - Al-Khafaji, Jaafar
AU  - Al-Khafaji J
AD  - Department of Internal Medicine University of Nevada Reno School of Medicine Reno 
      NV.
FAU - Gullapalli, Nageshwara
AU  - Gullapalli N
AD  - Department of Internal Medicine University of Nevada Reno School of Medicine Reno 
      NV.
FAU - Beutler, Bryce D
AU  - Beutler BD
AD  - Department of Internal Medicine University of Nevada Reno School of Medicine Reno 
      NV.
FAU - Boampong-Konam, Killian
AU  - Boampong-Konam K
AD  - Ghana Airport Clinc Limited Kotoka Internal Airport P.M.B KIA Accra Ghana.
FAU - Doshi, Rajkumar
AU  - Doshi R
AD  - Department of Internal Medicine University of Nevada Reno School of Medicine Reno 
      NV.
LA  - eng
PT  - Comparative Study
PT  - Journal Article
DEP - 20200510
PL  - England
TA  - J Am Heart Assoc
JT  - Journal of the American Heart Association
JID - 101580524
SB  - IM
CIN - J Am Heart Assoc. 2020 May 18;9(10):e016032. PMID: 32389052
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Databases, Factual
MH  - Early Detection of Cancer
MH  - Female
MH  - Health Status Disparities
MH  - Heart Neoplasms/diagnosis/*epidemiology/mortality
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Prevalence
MH  - Risk Assessment
MH  - Risk Factors
MH  - SEER Program
MH  - Sex Factors
MH  - Time Factors
MH  - United States/epidemiology
MH  - Young Adult
PMC - PMC7660836
OTO - NOTNLM
OT  - Surveillance, Epidemiology, and End Results
OT  - cardiac tumors
OT  - malignancy
OT  - sex
OT  - survival rate
EDAT- 2020/05/12 06:00
MHDA- 2021/03/11 06:00
PMCR- 2020/05/18
CRDT- 2020/05/12 06:00
PHST- 2020/05/12 06:00 [pubmed]
PHST- 2021/03/11 06:00 [medline]
PHST- 2020/05/12 06:00 [entrez]
PHST- 2020/05/18 00:00 [pmc-release]
AID - JAH34869 [pii]
AID - 10.1161/JAHA.119.014846 [doi]
PST - ppublish
SO  - J Am Heart Assoc. 2020 May 18;9(10):e014846. doi: 10.1161/JAHA.119.014846. Epub 
      2020 May 10.